Plain-English translation of NCT07256249 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study following nearly 1,000 patients who receive a special balloon coated with sirolimus (a medication that helps prevent arteries from re-closing) to treat blocked heart arteries. Researchers want to understand how well and safely this treatment works in everyday patients like you, outside of a strict research setting.
After a balloon treatment opens a blocked artery, sometimes the artery can narrow again. This study is tracking whether this medication-coated balloon can prevent that re-narrowing and keep arteries open longer, and whether it's safe for patients with different types of heart artery blockages.
You likely qualify if…
You likely don't qualify if…
You would receive the special balloon treatment as planned by your doctor. After that, you would be followed for 12 months, during which researchers would check on your heart health and whether you experience any complications. This involves regular follow-up visits and possibly some heart tests, but you are not required to take any extra medications or make major lifestyle changes beyond your normal care.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
Portugal